Sergina, Natalia V <br/><br/>
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3.  [electronic resource] 

 -  Nature  Jan 2007 
 - 437-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-4687 
<br/><br/><label>Standard No.: </label>10.1038/nature05474  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--drug therapy<br/>ErbB Receptors--antagonists & inhibitors<br/>Feedback, Physiological<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Receptor, ErbB-3--metabolism<br/>Signal Transduction<br/>Substrate Specificity